Marksans Pharma Ltd.
| BSE: 524404 | Sector: Health care |
| NSE: MARKSANS | ISIN Code: INE750C01026 |
| BSE 09:42 | 01 Jul | 43.70 |
0 (0.00%) |
OPEN
43.40 |
HIGH
44.55 |
LOW
43.40 |
| NSE 09:29 | 01 Jul | 44.50 |
0.90 (2.06%) |
OPEN
44.25 |
HIGH
44.70 |
LOW
43.80 |
| OPEN | 43.40 |
| PREVIOUS CLOSE | 43.70 |
| VOLUME | 18060 |
| 52-Week high | 93.50 |
| 52-Week low | 38.70 |
| P/E | 17.20 |
| Mkt Cap.(Rs cr) | 1,789 |
| Buy Price | 43.55 |
| Buy Qty | 11.00 |
| Sell Price | 43.65 |
| Sell Qty | 501.00 |
Marksans Pharma Ltd. (MARKSANS) - Announcements
-
Marksans Pharma Ltd Closure of Trading Window
30/06/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
21/06/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
20/06/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Updates on Acquisition
10/06/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Dis
10/06/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06/06/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
02/06/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
01/06/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
01/06/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Board recommends Final Dividend
31/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Statement On Deviation Or Variation Of Funds Raised Through Preferential Issue Of Convertible Warran
30/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
30/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
30/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Investor Presentation
30/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Board Meeting Outcome for Outcome Of Board Meeting
30/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Audited Financial Results For The Quarter And Financial Year Ended 31St March 2022 And Auditors Repo
30/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
26/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
24/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Change In Office Address Of Registrar And Transfer Agent Of The Company
17/05/2022 | bse |
Downlaod PDF -
Marksans Pharma Ltd Board to consider FY22 results & Dividend on May 30 2022
16/05/2022 | bse |
Downlaod PDF
Quick Links for Marksans Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
